{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:21:40Z","timestamp":1762309300569,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nrleng.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:15:13Z","timestamp":1762308913000},"page":"830-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease"],"prefix":"10.1016","volume":"40","author":[{"given":"L.","family":"Busteed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Horta-Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Reig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Garc\u00eda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pascual-Sedano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Gich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Roy Ciffone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2025.08.001_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jnp.12053","article-title":"Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease","volume":"10","author":"Lee","year":"2016","journal-title":"J Neuropsychol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0335","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.psychres.2013.08.045","article-title":"Behavioral abnormalities in progressive supranuclear palsy","volume":"210","author":"Gerstenecker","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0340","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0345","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2990.2003.00463.x","article-title":"Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies","volume":"29","author":"De Silva","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0350","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0355","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2217\/nmt-2016-0027","article-title":"Managing cognition in progressive supranuclear palsy","volume":"6","author":"Rittman","year":"2016","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.22946","article-title":"Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis","volume":"25","author":"Rohrer","year":"2010","journal-title":"Movement Disord"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0365","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/WCO.0b013e3283168ddd","article-title":"Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy","volume":"21","author":"Josephs","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0370","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00401-003-0682-5","article-title":"Progressive supranuclear palsy presenting with primary progressive aphasia \u2013 clinicopathological report of an autopsy case","volume":"105","author":"Mochizuki","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0375","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Movement Disord"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0380","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","article-title":"Range of neuropsychiatric disturbances in patients with Parkinson's disease","volume":"67","author":"Aarsland","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0385","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1468-1331.9.s3.3.x","article-title":"The differential diagnosis of Parkinson's disease","volume":"9","author":"Poewe","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0390","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.25872","article-title":"Cognition in corticobasal syndrome and progressive supranuclear palsy: a review","volume":"29","author":"Burrell","year":"2014","journal-title":"Movement Disord"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0395","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/arclin\/acs098","article-title":"Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy","volume":"28","author":"Gerstenecker","year":"2013","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0400","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1007\/s00415-021-10511-y","article-title":"Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes","volume":"268","author":"Horta-Barba","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0405","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/07317115.2019.1694115","article-title":"The progressive supranuclear palsy: past and present aspects","volume":"43","author":"Parthimos","year":"2020","journal-title":"Clin Gerontol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0410","first-page":"1","article-title":"Sensitivity and specificity of the ECAS in Parkinson's disease and progressive supranuclear palsy","volume":"2018","author":"Foley","year":"2018","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0415","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/mds.20779","article-title":"Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease","volume":"21","author":"Cordato","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0420","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cortex.2019.02.013","article-title":"The language profile of progressive supranuclear palsy","volume":"115","author":"Catrical\u00e0","year":"2019","journal-title":"Cortex"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0425","doi-asserted-by":"crossref","first-page":"107772","DOI":"10.1016\/j.neuropsychologia.2021.107772","article-title":"Phonemic fluency quantity and quality: comparing patients with PSP, Parkinson's disease and focal frontal and subcortical lesions","volume":"153","author":"Foley","year":"2021","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0430","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.neuropsychologia.2006.01.002","article-title":"Dynamic aphasia in progressive supranuclear palsy: a deficit in generating a fluent sequence of novel thought","volume":"44","author":"Robinson","year":"2006","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0435","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/jnp.13.1.42","article-title":"Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease","volume":"13","author":"Aarsland","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0440","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jnnp.60.4.403","article-title":"Progressive supranuclear palsy presenting with dynamic aphasia","volume":"60","author":"Esmonde","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0445","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pjnns.2015.05.004","article-title":"Writing in Richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia","volume":"49","author":"Sitek","year":"2015","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0450","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/brain\/114.3.1457","article-title":"Language functions in progressive supranuclear palsy","volume":"114","author":"Podoll","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0455","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/brain\/aws038","article-title":"Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease","volume":"135","author":"Ling","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0460","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamaneurol.2016.0412","article-title":"Features of patients with nonfluent\/agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration","volume":"73","author":"Santos-Santos","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0465","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/practneurol-2017-001635","article-title":"Communication changes in Parkinson's disease","volume":"17","author":"Miller","year":"2017","journal-title":"Pract Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/238956","article-title":"High-level language production in Parkinson's disease: a review","volume":"2011","author":"Altmann","year":"2011","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0475","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1017\/S1355617704104141","article-title":"Verbal fluency deficits in Parkinson's disease: a meta-analysis","volume":"10","author":"Henry","year":"2004","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0480","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.20718","article-title":"Action fluency in Parkinson's disease: a follow-up study","volume":"21","author":"Signorini","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0485","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cortex.2015.05.022","article-title":"Syntax, action verbs, action semantics, and object semantics in Parkinson's disease: dissociability, progression, and executive influences","volume":"69","author":"Bocanegra","year":"2015","journal-title":"Cortex"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0490","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1044\/jslhr.4306.1350","article-title":"Spoken language production in Huntington's and Parkinson's diseases","volume":"43","author":"Murray","year":"2000","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0495","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1468-1331.2007.01797.x","article-title":"Action and object naming in Parkinson's disease without dementia","volume":"14","author":"Cotelli","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0500","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0505","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a frontal assessment battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0510","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00702-013-1004-2","article-title":"Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease","volume":"120","author":"Biundo","year":"2013","journal-title":"J Neural Transm"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0515","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pjnns.2014.12.002","article-title":"Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy","volume":"49","author":"Sitek","year":"2015","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0520","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","article-title":"Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease","volume":"73","author":"Hoops","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0525","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00702-016-1589-3","article-title":"Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy","volume":"123","author":"Fiorenzato","year":"2016","journal-title":"J Neural Transm"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0530","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/01688638408401233","article-title":"Cued recall in amnesia","volume":"6","author":"Buschke","year":"1984","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0535","series-title":"BDAE: The Boston Diagnostic Aphasia Examination","author":"Goodglass","year":"2001"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0540","series-title":"The Boston Naming Test","author":"Kaplan","year":"1983"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0545","series-title":"A compendium of neuropsychological tests: administration, norms, and commentary","author":"Strauss","year":"2006"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0550","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/arclin\/acp042","article-title":"Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal fluency tests","volume":"24","author":"Pe\u00f1a-Casanova","year":"2009","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0555","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0010-9452(78)80006-9","article-title":"Normative data and screening power of a shortened version of the Token Test","volume":"14","author":"De Renzi","year":"1978","journal-title":"Cortex"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0560","series-title":"The Mississippi Aphasia Screening Test","first-page":"71","author":"Nakase-Thompson","year":"2004"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0565","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/mds.22007","article-title":"Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease","volume":"23","author":"Pagonabarraga","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0570","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13554799808410610","article-title":"The neuropsychology of progressive supranuclear palsy","volume":"4","author":"Bak","year":"1998","journal-title":"Neurocase"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0575","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00878659","article-title":"Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy","volume":"243","author":"Esmonde","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0580","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/jnnp.57.11.1389","article-title":"Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy","volume":"57","author":"Rosser","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0585","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00702-003-0011-0","article-title":"Differentiation of parkinsonian syndromes according to differences in executive functions","volume":"110","author":"Lange","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0590","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/01.wnl.0000267643.24870.26","article-title":"Frontal presentation in progressive supranuclear palsy","volume":"69","author":"Kaat","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0595","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/cercor\/bhp023","article-title":"Structural correlates of semantic and phonemic fluency ability in first and second languages","volume":"19","author":"Grogan","year":"2009","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0600","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/156720511795563809","article-title":"Recent advances in progressive supranuclear palsy: a review","volume":"8","author":"Kaat","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0605","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00415-019-09463-1","article-title":"Language impairment in progressive supranuclear palsy and corticobasal syndrome","volume":"268","author":"Peterson","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0610","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuropsychologia.2018.09.004","article-title":"Energization and spoken language production: evidence from progressive supranuclear palsy","volume":"119","author":"Barker","year":"2018","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jnnp-2012-303618","article-title":"The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders","volume":"84","author":"Rittman","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0620","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/13554790590963004","article-title":"Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia","volume":"11","author":"Josephs","year":"2005","journal-title":"Neurocase"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0625","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcomdis.2015.06.002","article-title":"Communication impairments in people with progressive supranuclear palsy: a tutorial","volume":"56","author":"Kim","year":"2015","journal-title":"J Commun Disord"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0630","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1016\/S1353-8020(08)70028-2","article-title":"Unraveling progressive supranuclear palsy: from the bedside back to the bench","volume":"13","author":"Houghton","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0635","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1531-8249(199901)45:1<65::AID-ART12>3.0.CO;2-1","article-title":"Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy","volume":"45","author":"Schulz","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0640","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1007\/s00415-018-9038-x","article-title":"Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy","volume":"265","author":"Santangelo","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0645","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00415-019-09324-x","article-title":"Motor, cognitive and behavioral differences in MDS PSP phenotypes","volume":"266","author":"Picillo","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.001_bib0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223621","article-title":"Clinical use of SAND battery to evaluate language in patients with progressive supranuclear palsy","volume":"14","author":"Picillo","year":"2019","journal-title":"PLoS One"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:17:09Z","timestamp":1762309029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580825000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2173580825000781"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.08.001","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}